We used detailed methods to evaluate the composition of the tumor microenvironment, including CLR, infiltrating CD3+ and CD8+ lymphocytes, and the expression of checkpoint inhibition pathway proteins PD‐1/PD‐L1 on CD3 + lymphocytes, CD68+ macrophages, and tumor cells. The gene discussed is CD68; the disease is neoplasm.